1-2 of 2
Emmanuel Papadakis
Close
Sort by
Journal Articles

Ruxolitinib Remains Effective in Myelofibrosis after the Necessary Dose Reductions: Real-Life Data from a Multi-Center Observational Study

Damianos Sotiropoulos, Vassilios Papadopoulos, Maria Dimou, Despoina Kyriakou, George Papaioannou, George Karavalakis, Chara Giatra, Alexandra Kourakli, Polyxeni Lampropoulou, Maria Palasopoulou, Anastasia Banti, Nora-Athina Viniou, Theodoros Marinakis, Eleftheria Hatzimichael, Evdoxia Hatjiharissi, Diamantina Vasilatou, Emmanuel Papadakis, George Vassilopoulos, MDPhD, Panagiotis Repousis, Taxiarchis Kourelis, Nikolaos Harhalakis, Argiris S. Symeonidis, Panayiotis Panayiotidis, MDPhD, Achilles Anagnostopoulos, MD
Journal: Blood
Blood (2016) 128 (22): 5476.
https://doi.org/10.1182/blood.V128.22.5476.5476
Published: 2016
Journal Articles

Ruxolitinib Efficacy and Safety in Myelofibrosis: A Multicenter Observational Study

Damianos Sotiropoulos, Vassilios Papadopoulos, Maria Dimou, Despoina Kyriakou, George Papaioannou, George Karavalakis, Emmanuel Papadakis, Maria Palasopoulou, Anastasia Banti, Taxiarchis Kourelis, Alexandra Kouraklis, Theodoros Marinakis, Nora-Athina Viniou, Eleftheria Hatzimichael, Diamantina Vasilatou, George Vassilopoulos, MDPhD, Panayiotis Panayiotidis, Achilles Anagnostopoulos
Journal: Blood
Blood (2015) 126 (23): 5192.
https://doi.org/10.1182/blood.V126.23.5192.5192
Published: 2015